Here are some. Hope it helps.
SM
Target: Metal Bulletin plc
(UK based publisher and information provider )
Bidder: Euromoney Institutional Investor plc
(UK based publishing company which is involved in the international publishing and events business.)
Value: GBP227m Nature: Recommended
Date: 04/08/2006 Type: Acquisition, Domestic, Public
Description: Euromoney Institutional Investor, the UK listed publisher and information provider, has agreed to acquire the entire issued share capital of Metal Bulletin Plc, its UK listed counterpart.
TERMS
Euromoney Institutional Investor is offering GBP 4.00 per share in cash per share for the entire issued share capital of Metal Bulletin.
The offer represents a premium of 4.23% to Metal Bulletin's GBP 3.8375 closing price on 03-August-2006, last trading day prior to the firm announcement of the offer; and a premium of 32.7 per cent. to Metal Bulletin's share pr...
---
Hardys & Hansons plc
(UK based pub operator.)
Bidder: Greene King plc
(UK based brewer and pub operator.)
Value: GBP272m Nature: Recommended
Date: 15/06/2006 Type: Acquisition, Domestic, Public
Description: Greene King plc, UK based pub retailer and ale brewer., has made a recommended offer to acquire the entire issued and to be issued share capital of Hardys & Hansons plc, its domestic counterpart.
STRUCTURE
The offer will be executed via a recommended scheme of arrangement. Greene King has agreed to acquire the entire issued ordinary share capital of Hardys & Hansons as well as entire deferred ordinary share capital.
TERMS
The offer price per share is GBp 1059 in cash. In addition shareholders will be entitled to receive an interim dividend o...
---
Cambridge Antibody Technology Group plc (CAT)
(UK based biopharmaceutical company engaged in developing human monoclonal antibody therapeutics. Its activities include: inflammation, auto-immunity, allergy and asthma antibody/ drug research, user of functional genomics and proteomics platform technologies. )
Bidder: AstraZeneca plc
(UK based pharmaceutical company engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. AstraZeneca was formed on 6 April 1999 through the merger of Astra AB and Zeneca Group plc of the UK.)
Value: GBP551m Nature: Recommended
Date: 15/05/2006 Type: Acquisition, Domestic, Public
Description: AstraZeneca Plc, the UK-based pharmaceutical company, has launched a recommended public offer to acquire the entire issued and to be issued share capital of Cambridge Antibody technology Group Plc (CAT), the UK biopharmaceutical company.
TERMS
The offer will be executed via a recommended public offer.
Offer price per share is GBp 1320 in cash.
It values the entire issued share capital of CAT at GBP702m.
Shareholders can elect to receive Loan Notes issued by AstraZeneca on the following basis:
GBP 1 principal per GBP 1 consid...
---
MacLellan Group plc
(UK based provider of facilities management and engineering services.)
Bidder: Interserve plc (formerly Tilbury Douglas plc)
(UK based construction company also providing engineering and equipment services.)
Value: GBP126m Nature: Recommended
Date: 02/05/2006 Type: Acquisition, Domestic, Public
Description: Interserve plc, the listed UK based construction company, has agreed to acquire MacLellan Group plc, the listed UK based provider of facilities support services, for GBp 116 per share, valuing MacLellan's equity at approximately GBP 116m, based on approximately 99.68m shares outstanding.
Under the terms of the agreement, Interserve will also acquire MacLellan's convertible preference shares at GBp 40.6 per share for a total of GBP 2.03m. Interserve will pay the consideration either in cash to the extent of GBp 80 per share and in 0.0943 Interserve Shares valued at GBp 36 per share. The M...